Becton, Dickinson (BD) management’s board approval to pursue a plan to separate BD's Biosciences and Diagnostic Solutions business from the rest of the organisation could reflect the “packaging up” of ...

The president of BD’s life sciences division, Dave Hickey, is officially planning his retirement, with the calendar marked for July 1. Hickey has overseen BD’s portfolio of scientific research tools ...

Becton, Dickinson and Company BDX, popularly known as BD, is evaluating the divestment of its Life Sciences division as part of a broader strategic shift toward becoming a pure-play medtech company.

FRANKLIN LAKES, N.J., Aug. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michael Feld has been named ...